Risultati della ricerca - "ibrutinib"

A ROR1 Small Molecule Inhibitor (KAN0441571C) Induced Significant Apoptosis of Mantle Cell Lymphoma (MCL) Cells di Amineh Ghaderi, Wen Zhong, Mohammad Ali Okhovat, Johanna Aschan, Ann Svensson, Birgitta Sander, Johan Schultz, Thomas Olin, Anders Österborg, Mohammad Hojjat-Farsangi, Håkan Mellstedt

Connect to this object online.

Interfering B cell receptor signaling via SHP-1/p-Lyn axis shows therapeutic potential in diffuse large B-cell lymphoma di Ji-Lin Chen, Pei-Yi Chu, Chun-Teng Huang, Tzu-Ting Huang, Wan-Lun Wang, Yu-Hsuan Lee, Yuan-Ya Chang, Ming-Shen Dai, Chung-Wai Shiau, Chun-Yu Liu

Connect to this object online.

Development of a novel Bruton's tyrosine kinase inhibitor that exerts anti-cancer activities potentiates response of chemotherapeutic agents in multiple myeloma stem cell-like cell... di Weam Othman Elbezanti, Weam Othman Elbezanti, Omar S. Al-Odat, Omar S. Al-Odat, Robert Chitren, Robert Chitren, Jaikee Kumar Singh, Sandeep Kumar Srivastava, Krishne Gowda, Shantu Amin, Gavin P. Robertson, Venkatesh V. Nemmara, Subash C. Jonnalagadda, Tulin Budak-Alpdogan, Manoj K. Pandey

Connect to this object online.

Multicriteria analysis of the assortment of innovative drugs in oncohematology as a tool for supporting decision-making in the field of drug provision di S. V. Nedogoda, A. S. Salasyuk, I. N. Barykina, V. O. Smirnova, E. A. Popova

Connect to this object online.

Combining BTK inhibitors with BCL2 inhibitors for treating chronic lymphocytic leukemia and mantle cell lymphoma di Jing Zhang, Xueying Lu, Jianyong Li, Yi Miao

Connect to this object online.

Recent Advances in Covalent Drug Discovery di Daniel Schaefer, Xinlai Cheng

Connect to this object online.

Multiwalled Carbon Nanotubes as Nanomaterial Tool in the Management of Prostate Cancer: A Possible Nanoformulation Approach di Raja Murugesan, Raman Sureshkumar, Arun Radhakrishnan, Srikanth Jupudi, Manisha Chennu

Connect to this object online.

Overcoming phenotypic switching: targeting protein-protein interactions in cancer di Christos Ladias, Pavlos Papakotoulas, Maria Papaioannou, Nikolaos A. Papanikolaou

Connect to this object online.

Targeted treatment for chronic lymphocytic leukemia: clinical potential of obinutuzumab di Smolej L

Connect to this object online.

The TKI Era in Chronic Leukemias di Danilo De Novellis, Fabiana Cacace, Valeria Caprioli, William G. Wierda, Kris M. Mahadeo, Francesco Paolo Tambaro

Connect to this object online.

Drug repurposing for rheumatoid arthritis: Identification of new drug candidates via bioinformatics and text mining analysis di Ulku Unal, Betul Comertpay, Talip Yasir Demirtas, Esra Gov

Connect to this object online.

Atrial Fibrillation Associated with Anticancer Drugs di O. D. Ostroumova, M. S. Chernyaeva, A. I. Kochetkov, D. I. Bakhteeva, S. N. Ivanov, D. A. Sychev

Connect to this object online.

Photoredox-catalyzed reaction as a powerful tool for rapid natural product Gem -dimethylation modification: discovery of potent anti-cancer agents with improved druggability di Chao Zhang, Yugang Song, Xiuyun Sun, Qianlong Liu, Zhen Li, Shenyi Yin, Jianzhong Jeff Xi, Xin Zhai, Yu Rao

Connect to this object online.

Availability of comparative real-world evidence research in Medicare patients: implications for Centers for Medicare and Medicaid Services drug price negotiations di Ashley Jaksa, Patrick J Arena, Nicolle Gatto

Connect to this object online.

Development of venetoclax for therapy of lymphoid malignancies di Zhu H, Almasan A

Connect to this object online.

Targeted therapies in CLL/SLL and the cumulative incidence of infection: A systematic review and meta-analysis di Stephanos Vassilopoulos, Stephanos Vassilopoulos, Fadi Shehadeh, Fadi Shehadeh, Fadi Shehadeh, Markos Kalligeros, Markos Kalligeros, Quynh-Lam Tran, Quynh-Lam Tran, Fred Schiffman, Fred Schiffman, Eleftherios Mylonakis, Eleftherios Mylonakis

Connect to this object online.

Emerging B-Cell Therapies in Systemic Lupus Erythematosus di Bag-Ozbek A, Hui-Yuen JS

Connect to this object online.

A Small Molecule Targeting the Intracellular Tyrosine Kinase Domain of ROR1 (KAN0441571C) Induced Significant Apoptosis of Non-Small Cell Lung Cancer (NSCLC) Cells di Amineh Ghaderi, Mohammad-Ali Okhovat, Jemina Lehto, Luigi De Petris, Ehsan Manouchehri Doulabi, Parviz Kokhaei, Wen Zhong, Georgios Z. Rassidakis, Elias Drakos, Ali Moshfegh, Johan Schultz, Thomas Olin, Anders Österborg, Håkan Mellstedt, Mohammad Hojjat-Farsangi

Connect to this object online.

HIF-PH Encoded by <i>EGLN1</i> Is a Potential Therapeutic Target for Chronic Lymphocytic Leukemia di Wancheng Guo, Daomiao Liang, Peilong Wang, Le Yin, Huifang Zhang, Cheng Xing, Zineng Huang, Yinghua Wu, Heng Li, Zhao Cheng, Xiaojuan Xiao, Jing Liu, Zhihua Wang, Hongling Peng

Connect to this object online.

ZYBT1, a potent, irreversible Bruton's Tyrosine Kinase (BTK) inhibitor that inhibits the C481S BTK with profound efficacy against arthritis and cancer di Krishnarup Ghoshdastidar, Hoshang Patel, Hitesh Bhayani, Ankit Patel, Kinjal Thakkar, Dinesh Patel, Manoranjan Sharma, Jaideep Singh, Jogeswar Mohapatra, Abhijit Chatterjee, Dipam Patel, Rajesh Bahekar, Rajiv Sharma, Lakshmikant Gupta, Nirmal Patel, Poonam Giri, Nuggehally R. Srinivas, Mukul Jain, Debdutta Bandyopadhyay, Pankaj R. Patel, Ranjit C. Desai

Connect to this object online.